Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel E. Handley currently holds 11,040 shares of Predictive Oncology Inc. (POAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel E. Handley has been a net buyer of POAI stock. They have purchased $8.0K and sold $0 worth of shares.
Daniel E. Handley's most recent insider trade was on Apr 20, 2026, when they sold 5,663 shares at $0.00 per share.
Daniel E. Handley serves as Executive at Predictive Oncology Inc. (POAI). They have executed 19 insider transactions totaling $8.0K over their tenure at the company.
Daniel E. Handley holds the position of Executive at Predictive Oncology Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Daniel E. Handley has shown a buying trading pattern, with $8.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Daniel E. Handley was on Nov 29, 2022, when they purchased $3.6K worth of POAI shares. This transaction involved 10,000 shares at $0.36 per share.
Daniel E. Handley currently owns 11,040 shares of Predictive Oncology Inc. (POAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel E. Handley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel E. Handley has 19 Form 4 filings on record as an insider at Predictive Oncology Inc..
Set alerts for Daniel E. Handley and 40,000+ other insiders.